Sign in

CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
  1. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $11.07 ($110,700)
  2. 4 Open-market sale Director sold 71,371 shares at an average $10.12 ($722,299)
  3. 8-K Event Other events
  4. 4 Open-market sale Director sold 1,898 shares at $9.01 ($17,101)
  5. 4 Open-market sale Director sold 201,731 shares at an average $8.42 ($1,697,614)
  6. 4 Open-market sale Director sold 7,500 shares at $8.13 ($60,975)
  7. 4 Open-market sale Chief Executive Officer sold 125,000 shares at $9.80 ($1,225,000)
  8. 4 Open-market sale Chief Financial Officer sold 7,990 shares at $9.96 ($79,580)
  9. 8-K Event Material agreement
  10. 4 Open-market sale Chief Executive Officer sold 125,000 shares at $7.52 ($940,000)
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Other events
  13. 4 Open-market sale Chief Financial Officer sold 30,000 shares at $7.22 ($216,600)
  14. 424B7 Offering Prospectus
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations · Regulation FD disclosure · Other events
  17. 4 Open-market sale Director sold 10,000 shares at $6.81 ($68,072)
  18. 4 Open-market sale Director sold 7,500 shares at $6.40 ($48,000)
  19. 8-K Event Other events
  20. 4 Open-market sale Chief Financial Officer sold 31,086 shares at $6.70 ($208,276)

Page 19 of 45 · 895 filings